Cristina Lopez-Espada

Cristina Lopez-Espada

Auto-generated profile, based on publicly available information

Cristina Lopez-Espada

Department of Surgery, University Hospital Virgen de las Nieves, University of Granada, Granada, Spain

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 August 2022 in European Journal of Vascular and Endovascular Surgery
Verified
Journal Article
Open access
HAHelene Arndt
Helene Arndt
JNJoakim Nordanstig
Joakim Nordanstig
DBDaniel J. Bertges
Daniel J. Bertges
JBJacob William Budtz-Lilly
Jacob William Budtz-Lilly
MVMaarit Venermo
Maarit Venermo
Christian Alexander BehrendtChristian Alexander Behrendt
Christian Alexander Behrendt
This study aimed to develop a core set of patient reported outcome quality indicators (QIs) for the treatment of patients with intermittent claudication (IC), that allow a broad international implementation across different vascular registries and within trials. A rigorous modified two stage Delphi technique was used to promote consensus building on patient reported outcome QIs among an expert panel consisting of international vascular specialists, patient representatives, and registry members of the VASCUNET and the International Consortium of Vascular Registries. Potential QIs identified through an extensive literature search or additionally proposed by the panel were validated by the experts in a preliminary survey and included for evaluation. Consensus was reached if ≥ 80% of participants agreed that an item was both clinically relevant and practical. Participation rates in two Delphi rounds were 66% (31 participants of 47 invited) and 90% (54 of 60), respectively. Initially, 145 patient reported outcome QIs were documented. Following the two Delphi rounds, 18 quality indicators remained, all of which reached consensus regarding clinical relevance. The VascuQoL questionnaire (VascuQoL-6), currently the most common patient reported outcome measurement (PROM) used within vascular registries, includes a total of six items. Five of these six items also matched with high rated indicators identified in the Delphi study. Consequently, the panel recommends the use of the VascuQoL-6 survey as a preferred core PROM QI set as well as an optional extension of 12 additional patient reported QIs that were also identified in this study. The current recommendation based on the Delphi consensus building approach, strengthens the international harmonisation of registry data collection in relation to patient reported outcome quality. Continuous and standardised quality assurance will ensure that registry data may be used for future quality benchmarking studies and, ultimately, positively impact the overall quality of care provided to patients with peripheral arterial occlusive disease.

23 July 2023 in European Journal of Vascular and Endovascular Surgery
Verified
Journal Article
Closed access
CECristina Lopez Espada
Cristina Lopez Espada
CBChristian-Alexander Behrendt
Christian-Alexander Behrendt
KMKevin Mani
Kevin Mani
Mario D’OriaMario D’Oria
Mario D’Oria
TLThomas Lattman
Thomas Lattman
JBJacob William Budtz-Lilly
Jacob William Budtz-Lilly

30 April 2024 in European Journal of Vascular and Endovascular Surgery
Verified
Journal Article
Open access
APAnna Louise Pouncey
Anna Louise Pouncey
LMLorenz Meuli
Lorenz Meuli
CLCristina Lopez-Espada
Cristina Lopez-Espada
JBJacob William Budtz-Lilly
Jacob William Budtz-Lilly
JBJonathan R Boyle
Jonathan R Boyle
SWSam Waton
Sam Waton
Vascular surgery registries report on procedures and outcomes to promote patient safety and drive quality improvement. International registries have significantly contributed to the VASCUNET collaborative abdominal aortic aneurysm (AAA) outcome projects. This scoping review aimed to outline the national registries in vascular surgery that currently participate in the VASCUNET collaborative AAA projects. A scoping review of all published VASCUNET AAA studies and validation reports between 1997 and 2024 was undertaken. A survey was conducted among representatives of the international vascular registries contributing to VASCUNET collaborative AAA projects. Currently, vascular registries from 10 countries (Australia, Denmark, Finland, Hungary, Iceland, New Zealand, Norway, Sweden, Switzerland, and the UK) contribute to the current VASCUNET collaborative AAA project, of which eight have national coverage. In the past, three countries (Germany, Malta, and Italy) have participated in previous VASCUNET AAA projects, and a further three countries (Serbia, Greece, and Portugal) have planned participation in future projects. External validity is high for all current registries, with most reporting rates of > 90%. The majority have internal validation processes to assess data accuracy. VASCUNET mediated validation has also been performed by the consortium for five countries to date (Hungary, Sweden, Denmark, Malta, and Switzerland), for which a high degree of external and internal validity was identified. Most registries have established mechanisms for data linkage with national administrative datasets or insurance claims datasets, and contribute to quality improvement through regular reporting to participating centres. National vascular registries from nations participating in the VASCUNET collaborative AAA projects are largely comprehensive, with high case ascertainment rates and good quality data with internal quality assurance. This provides a template for new registries wishing to join the VASCUNET collaboration and a benchmark for future research.

1 July 2004 in European Journal of Vascular and Endovascular Surgery
Verified
Journal Article
Open access
NMN Maldonado-Fernández
N Maldonado-Fernández
CLC Lopez-Espada
C Lopez-Espada
JMJ Moreno-Escobar
J Moreno-Escobar
JMJ Martinez-Gámez
J Martinez-Gámez
ARA Rodriguez-Morata
A Rodriguez-Morata
VGV Garcı́a-Róspide
V Garcı́a-Róspide
Background. Adventitial cystic disease of the veins affects the vessels of the lower limbs, and often appears in the femoral region. The disease presents as swelling of the extremity of several months' evolution. Phlebography shows extrinsic compression of the vein without thrombosis. Simple resection of the cyst leads to better results than does transcutaneous aspiration or drainage.Clinical case. We describe a 56-year-old woman who presented with a swollen left leg. Phlebography showed extrinsic compression of the external iliac vein by a 4 cm cystic mass. Surgical resection of the cyst was followed by recurrence in the retroperitoneal abdominal cavity

9 September 2025 in European Journal of Vascular and Endovascular Surgery
Verified
Journal Article
Open access
LMLorenz Meuli
Lorenz Meuli
HGHamid Gavali
Hamid Gavali
JBJacob Budtz-Lilly
Jacob Budtz-Lilly
MKManar Khashram
Manar Khashram
TLThomas Lattmann
Thomas Lattmann
KMKevin Mani
Kevin Mani
To examine trends in treatment strategies and perioperative outcomes for intact and ruptured complex abdominal aortic aneurysms (cAAA) across seven countries. Multinational, registry-based observational study within the VASCUNET framework. This study used aggregated data from vascular registries in Australia, Denmark, Finland, New Zealand, Portugal, Sweden, and Switzerland. Patients treated with open repair (OR) and fenestrated (or branched) endovascular aortic repair (F/BEVAR) for intact and ruptured cAAA between 2018-2022 were included. The primary outcome was perioperative mortality (30-day or in-hospital). Weighted perioperative mortality rates with 95% confidence intervals (95%-CI) were calculated and variations in treatment practices and outcomes were assessed. 3344 patients treated for intact cAAA, and 547 patients treated for ruptured cAAA were included. An overall increase in the use of F/BEVAR for intact cAAA was observed, rising from 50% in 2018 to 54% in 2022, with Denmark showing the largest rise, from 33% to 71%. The highest F/BEVAR rate was seen in Australia at 68%, the lowest in Switzerland at 25%. In contrast, OR was the predominant treatment for ruptured cAAA, accounting for 94% of all procedures without a clear trend. The overall perioperative mortality for intact cAAA decreased from 5.2% (95%-CI: 3.3-7.0%) in 2018 to 2.4% (1.3-3.5%) in 2022, though the trend was not statistically significant (p=.09). No time trend was observed in the perioperative mortality for ruptured cAAA, with an overall mortality rate of 35.6%. Complication rates, including myocardial infarction, acute kidney failure, and respiratory failure were more frequent in OR patients. While the use of F/BEVAR for elective cAAA repair has increased and mortality rates show a declining trend, the treatment of ruptured cAAA continues to rely predominantly on OR, with high perioperative mortality rates. These findings highlight the need for ongoing advancements in endovascular technologies for ruptured cAAA repairs.

23 June 2022 in Journal of Endovascular Therapy
Verified
Journal Article
Closed access
CLCristina Lopez-Espada
Cristina Lopez-Espada
JLJose Linares-Palomino
Jose Linares-Palomino
MRMercedes Guerra Requena
Mercedes Guerra Requena
FHFrancisco Javier Serrano Hernando
Francisco Javier Serrano Hernando
EOElena Iborra Ortega
Elena Iborra Ortega
LMLivia Revuelta Mariño
Livia Revuelta Mariño
Purpose: The widespread adoption of endovascular aneurysm repair (EVAR) as preferred treatment modality for abdominal aortic aneurysm (AAA) has enlarged the number of patients needing open surgical conversion (OSC). The relationship between adherence to Instructions For Use (IFU) and EVAR long-term outcomes remains controversial. The aim of this study is to compare preoperative differences and postoperative outcomes between EVAR patients not adjusted to IFU and adjusted to IFU who underwent OSC. Methods: This multicenter retrospective study reviewed 33 explanted EVARs between January 2003 and December 2019 at 14 Vascular Units. Patients were included if OSC occurred >30 days after implantation and excluded if explantation was performed to treat an endograft infection, aortic dissection, or traumatic transections. Variables analyzed included baseline characteristics, adherence to IFU, implant and explant procedural details, secondary reinterventions, and postoperative outcomes. Results: Fifteen explanted patients (15/33, 45.5%) were identified not accomplished to IFU (out-IFU) at initial EVAR vs 18 explanted patients adjusted (in-IFU). During follow-up, a mean of 1.73±1.2 secondary reinterventions were performed, with more type I endoleaks treated in the subgroup out-IFU: 16.7% vs 6.3% in-IFU patients and more type III endoleaks (8.3% vs 0%). Patients out-IFU had shorter mean interval from implant to explant: 47.60±28.8 months vs 71.17±48. Type II endoleak was the most frequent indication for explantation. Low-flow endoleaks (types II, IV, V) account for 44% of indications for OSC in subgroup of patients in-IFU, compared with 13.3% in patients out-IFU and high-flow endoleaks (types I and III) were the main indication for patients out-IFU (33.3% vs 16.7% in-IFU). Total endograft explantation was performed in 57.5% of cases (19/33) and more suprarenal clamping was required in the subgroup out-IFU. Overall, 30-day mortality rate was 12.1% (4/33): 20% for patients out-IFU and 5.6% in-IFU. Conclusions: In our experience, type II endoleak is the most common indication for conversion and differences have been found between patients treated outside IFU with explantation taking place earlier during follow-up, mainly due to high-flow endoleaks and with higher mortality in comparison with patients adjusted to IFU. Ongoing research is required to delve into these differences.